Wow, has anyone seen the COCP presentation - Antiviral Therapies? Amazing that COCP is the only company with Drug Resistant Crystals according to the presentation. Also, their Drug-resistant crystal pipeline developed. Finally, that their Technology Platform Focuses on Viral Replication
Drug Targets Through Cocrystalization. For all investors, do your DD. Nonetheless, in my opinion, COCP is a safe bet going forward with it's Technology platform developing new Drug. Please go to their website for more info.
Many Thanks CEO Jeff Meckler. Both 28th Annual ROTH Conference
On Mar. 14th at the Ritz-Carlton Laguna Niguel Hotel in Dana Point, Ca.
and at the Barclays Capital Global Healthcare Conference is all, I wanted,
and probably other investors, wanted to hear that you're getting the word
out on your recent developments. Again, many thanks.
A Long term investor.